Acasti Pharma Stock News

LAVAL, Québec, Nov. 24, 2021 (GLOBE NEWSWIRE) -- Acasti Pharma Inc. (Acasti or the Company) (Nasdaq: ACST and TSX-V: ACST), today announced that Jan DAlvise, President and CEO of Acasti Pharma, will be participating in the Benzinga All Access event taking place on December 2, 2021.

Acasti Pharma (NASDAQ:ACST) and Werewolf Therapeutics (NASDAQ:HOWL) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their profitability, risk, valuation, earnings, institutional ownership, analyst recommendations and dividends. Institutional and Insider Ownership 12.8% of Acasti Pharma shares are held by institutional investors. Comparatively, []

Acasti Pharma Inc. (CVE:ACST)s share price hit a new 52-week low during mid-day trading on Tuesday . The company traded as low as C$1.92 and last traded at C$1.92, with a volume of 7268 shares traded. The stock had previously closed at C$1.98. The stock has a market capitalization of C$85.92 million and a PE []

Laval, Quebec--(Newsfile Corp. - November 11, 2021) - Acasti Pharma Inc. (NASDAQ: ACST) (TSXV: ACST) ("Acasti" or the "Company"), today announced that management will present at the Q4 Investor Summit

Acasti Pharma Inc. (ACST) CEO Jan D'Alvise on Q3 2021 Results - Earning Call Transcript

Patents strengthen Acasti's IP portfolio and provide protection through 2036 and 2037, respectively Patents strengthen Acasti's IP portfolio and provide protection through 2036 and 2037, respectively

Study expected to be completed in the first half of 2022, with the goal to commence the Phase 3 safety study in the second half of 2022 Study expected to be completed in the first half of 2022, with t

LAVAL, Québec, Sept. 22, 2021 (GLOBE NEWSWIRE) -- Acasti Pharma Inc. (“Acasti” or the “Company”) (Nasdaq: ACST and TSX-V: ACST), today provided a business update and announced that the Nasdaq

LAVAL, Québec, Sept. 14, 2021 (GLOBE NEWSWIRE) -- Acasti Pharma Inc. (“Acasti” or the “Company”) (Nasdaq: ACST and TSX-V: ACST), today announced that it will be presenting at the Oppenheimer

The clinical-stage pharmaceutical company completed its merger with Grace Therapeutics last week.

LAVAL, Québec, Aug. 27, 2021 (GLOBE NEWSWIRE) -- Acasti Pharma Inc. (“Acasti”) (NASDAQ: ACST–TSX-V: ACST), announced today the completion of its previously disclosed acquisition of Grace Thera

Making a penny stocks watchlist in August? Check these 3 small-caps out The post Are These Penny Stocks on Your Watchlist Right Now?

LAVAL, Québec, July 29, 2021 (GLOBE NEWSWIRE) -- Acasti Pharma Inc. (“Acasti” or the “Company”) (Nasdaq: ACST and TSX-V: ACST) announces a reminder that it will host a business update confere

Which penny stocks are investors watching with August only a week away? The post Best Penny Stocks to Buy in August?

All shareholders are strongly encouraged to vote in advance of the August 26, 2021, annual and special meeting of shareholders All shareholders are strongly encouraged to vote in advance of the August